Pacific Shuanglin Bio-Pharmacy Co.,Ltd.’s Net Profit Dropped 35.5% in First Half of 2023

Pacific Shuanglin Bio-Pharmacy Co.,Ltd. (派斯双林生物制药股份有限公司) (000403.SZ) reported a net profit of 143 million yuan in the first half of 2023, down 35.5% year-on-year.

Meanwhile, the company posted 709.1 million yuan in revenue, down 28.5% year-on-year.

At the end of the reporting period, it had 8.1 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 14.3%.